Cargando…
A Novel Immune-Related Gene Prognostic Index (IRGPI) in Pancreatic Adenocarcinoma (PAAD) and Its Implications in the Tumor Microenvironment
SIMPLE SUMMARY: Pancreatic adenocarcinoma (PAAD) is one of the leading causes of cancer death across the world, with extremely poor clinical outcomes within 5 years. From that end, survival prediction for such patients is essential, while in-service biomarkers are in need to be improved. Therefore,...
Autores principales: | Zhou, Shujing, Szöllősi, Attila Gábor, Huang, Xufeng, Chang-Chien, Yi-Che, Hajdu, András |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688924/ https://www.ncbi.nlm.nih.gov/pubmed/36428747 http://dx.doi.org/10.3390/cancers14225652 |
Ejemplares similares
-
Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer
por: Jin, Yabin, et al.
Publicado: (2022) -
Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity
por: Huang, Xufeng, et al.
Publicado: (2022) -
PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD
por: Dong, Penggang, et al.
Publicado: (2023) -
Network Pharmacology-Based Approach Combined with Bioinformatic Analytics to Elucidate the Potential of Curcumol against Hepatocellular Carcinoma
por: Huang, Xufeng, et al.
Publicado: (2022) -
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)